Stocks
Gossamer Bio (GOSS) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 260.6% | 2 184% | 646.4% | 10 504% | 35 983% | 123 409% | |||
| Changes by years, y/y, % | +1 923pp | -1 538pp | +9 857pp | +25 479pp | +242.8% | ||||
Gossamer Bio. R&D/CAPEX, %
Gossamer Bio. R&D/CAPEX, changes, pp
Gossamer Bio (GOSS) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
| R&D/CAPEX, % | 35 477% | 251 967% | 242 060% | 104 000% | 49 463% | 123 409% | ||
| Changes by years, y/y, % | -138 265pp | +228 056pp | +210 519pp | +7 241pp | +13 986pp | |||
| Changes by quarters, q/q, % | -61 282pp | +216 490pp | -9 907pp | -138 060pp | -54 537pp | |||
